Kymera Therapeutics, Inc. SEC filings KYMR
Kymera Therapeutics, Inc. has 647 filings in SEC EDGAR's recent list, going back to Jun 22, 2020. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Feb 26, 2026 | — |
| 424B5 | Prospectus supplement | Feb 26, 2026 | — |
| S-8 | Employee stock plan registration | Feb 26, 2026 | — |
| 424B5 | Prospectus supplement | Dec 10, 2025 | — |
| 424B5 | Prospectus supplement | Dec 8, 2025 | — |
| 424B5 | Prospectus supplement | Jun 27, 2025 | — |
| 424B5 | Prospectus supplement | Jun 25, 2025 | — |
| S-8 | Employee stock plan registration | Feb 27, 2025 | — |
| S-3ASR | Automatic shelf registration | Oct 31, 2024 | — |
| 424B5 | Prospectus supplement | Aug 20, 2024 | — |
| 424B5 | Prospectus supplement | Aug 19, 2024 | — |
| S-8 | Employee stock plan registration | Feb 22, 2024 | — |
| 424B5 | Prospectus supplement | Jan 5, 2024 | — |
| 424B5 | Prospectus supplement | Jan 4, 2024 | — |
| S-8 | Employee stock plan registration | Feb 23, 2023 | — |
| 424B3 | Prospectus | Sep 6, 2022 | — |
| S-8 | Employee stock plan registration | Feb 24, 2022 | — |
| S-3ASR | Automatic shelf registration | Oct 1, 2021 | — |
| 424B4 | Prospectus | Jul 2, 2021 | — |
| S-1MEF | Filing | Jun 30, 2021 | — |
| S-1 | Registration statement | Jun 28, 2021 | — |
| S-8 | Employee stock plan registration | Mar 11, 2021 | — |
| S-8 | Employee stock plan registration | Aug 21, 2020 | — |
| 424B4 | Prospectus | Aug 21, 2020 | — |
| S-1MEF | Filing | Aug 20, 2020 | — |
| S-1/A | Amended registration statement | Aug 17, 2020 | — |
| S-1/A | Amended registration statement | Aug 13, 2020 | — |
| S-1/A | Amended registration statement | Aug 5, 2020 | — |
| S-1 | Registration statement | Jul 31, 2020 | — |
Showing 29 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- KYMR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Watertown, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1815442
- Former names
- Kymera Therapeutics, Inc. (until Oct 29, 2026)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.